Details for New Drug Application (NDA): 050784
✉ Email this page to a colleague
The generic ingredient in ZITHROMAX is azithromycin. There are thirty-two drug master file entries for this compound. Sixty-seven suppliers are listed for this compound. Additional details are available on the azithromycin profile page.
Summary for 050784
Tradename: | ZITHROMAX |
Applicant: | Pfizer |
Ingredient: | azithromycin |
Patents: | 0 |
Suppliers and Packaging for NDA: 050784
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZITHROMAX | azithromycin | TABLET;ORAL | 050784 | NDA | Pfizer Laboratories Div Pfizer Inc | 0069-3070 | 0069-3070-30 | 30 TABLET, FILM COATED in 1 BOTTLE (0069-3070-30) |
ZITHROMAX | azithromycin | TABLET;ORAL | 050784 | NDA | Pfizer Laboratories Div Pfizer Inc | 0069-3070 | 0069-3070-75 | 3 BLISTER PACK in 1 CARTON (0069-3070-75) / 3 TABLET, FILM COATED in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 500MG BASE | ||||
Approval Date: | May 24, 2002 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 050784
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | ZITHROMAX | azithromycin | TABLET;ORAL | 050784-001 | May 24, 2002 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription